Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Dec-22 8:09 AM View:  | Baudax Bio, Inc. (BXRX) | 15-Dec-22 | Purchase | 1,200 | $2.55 | $3,057.12 | 97% 1.24K to 2.44K | |
| 17-Jun-22 4:10 PM View: | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 387% 10.19K to 49.66K | |
| 23-Dec-21 5:45 PM View: | Baudax Bio, Inc. (BXRX) | 15-Dec-21 | Payment of Exercise | 18,636 | $0.31 | $5,777.16 | (5%) 375.35K to 356.72K | (14%) |
| 14-Dec-21 6:27 PM View: | Baudax Bio, Inc. (BXRX) | 05-Dec-21 | Payment of Exercise | 9,155 | $0.35 | $3,204.25 | (2%) 384.51K to 375.35K | 4% |
| 23-Sep-21 10:00 PM View: | Baudax Bio, Inc. (BXRX) | 22-Sep-21 | Market Purchase | 8,200 | $0.59 | $4,797.82 | 2% 376.31K to 384.51K | 3% |
| 10-May-21 4:12 PM View: | Baudax Bio, Inc. (BXRX) | 07-May-21 | Market Purchase | 6,000 | $0.83 | $4,992.00 | 2% 370.31K to 376.31K | 6% |
| 22-Apr-21 5:57 PM View: | Societal Cdmo, Inc. (SCTL) | 20-Apr-21 | Grant | 26,923 | -- | -- | 11% 249.65K to 276.57K | |
| 22-Jan-21 6:27 PM View: | Baudax Bio, Inc. (BXRX) | 20-Jan-21 | Grant | 65,435 | -- | -- | 21% 304.87K to 370.31K | |
| 20-Jan-21 7:54 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-21 | Payment of Exercise | 6,816 | $3.03 | $20,652.50 | (3%) 256.47K to 249.65K | |
| 20-Jan-21 7:54 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-21 | Option Exercise | 5,000 | -- | -- | 2% 251.47K to 256.47K | |
| 05-Jan-21 5:04 PM View: | Societal Cdmo, Inc. (SCTL) | 02-Jan-21 | Payment of Exercise | 5,599 | $3.09 | $17,300.90 | (2%) 257.07K to 251.47K | (< 1%) |
| 09-Dec-20 5:43 PM View: | Societal Cdmo, Inc. (SCTL) | 05-Dec-20 | Payment of Exercise | 34,128 | $2.30 | $78,494.40 | (12%) 291.19K to 257.07K | (30%) |
| 09-Dec-20 5:45 PM View: | Baudax Bio, Inc. (BXRX) | 05-Dec-20 | Payment of Exercise | 83,015 | $1.14 | $94,637.10 | (21%) 387.89K to 304.87K | |
| 20-Apr-20 4:32 PM View: | Societal Cdmo, Inc. (SCTL) | 17-Apr-20 | Market Sale (Planned) | 80,000 | $8.22 | $657,600.00 | (27%) 291.19K to 211.19K | 64% |
| 29-Jan-20 7:44 PM View: | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Payment of Exercise | 5,051 | $8.51 | $42,984.00 | (1%) 392.94K to 387.89K | |
| 29-Jan-20 7:44 PM View: | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Option Exercise | 19,070 | -- | -- | 5% 373.87K to 392.94K | |
| 22-Jan-20 5:44 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-20 | Payment of Exercise | 5,552 | $16.38 | $90,941.80 | (2%) 296.75K to 291.19K | 82% |
| 22-Jan-20 5:44 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-20 | Option Exercise | 5,000 | -- | -- | 2% 291.75K to 296.75K | |
| 03-Jan-20 4:51 PM View: | Societal Cdmo, Inc. (SCTL) | 02-Jan-20 | Payment of Exercise | 4,945 | $17.53 | $86,685.90 | (2%) 296.69K to 291.75K | 83% |
| 09-Dec-19 6:27 PM View: | Societal Cdmo, Inc. (SCTL) | 05-Dec-19 | Grant | 93,550 | -- | -- | 46% 203.14K to 296.69K | |
| 09-Dec-19 6:18 PM View: | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 323,958 | -- | -- | 649% 49.91K to 373.87K | |
| 15-May-19 4:06 PM View: | Societal Cdmo, Inc. (SCTL) | 13-May-19 | Option Exercise | 123,500 | $2.47 | $305,045.00 | 46% 269.45K to 392.95K | |
| 15-May-19 4:06 PM View: | Societal Cdmo, Inc. (SCTL) | 13-May-19 | Market Option Sale (Planned) | 123,500 | $8.89 | $1,097,890.00 | (31%) 392.95K to 269.45K | 62% |
| 15-May-19 4:06 PM View: | Societal Cdmo, Inc. (SCTL) | 13-May-19 | Market Sale (Planned) | 21,306 | $8.89 | $189,406.00 | (8%) 269.45K to 248.14K | 62% |
| 23-Jan-19 4:08 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-19 | Grant | 35,801 | -- | -- | 16% 225.01K to 260.81K | |
| 23-Jan-19 4:08 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-19 | Payment of Exercise | 1,425 | $7.99 | $11,385.80 | (< 1%) 265.81K to 264.38K | 58% |
| 23-Jan-19 4:08 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-19 | Option Exercise | 5,000 | -- | -- | 2% 260.81K to 265.81K | |
| 04-Jan-19 4:40 PM View: | Societal Cdmo, Inc. (SCTL) | 02-Jan-19 | Payment of Exercise | 4,223 | $7.41 | $31,292.40 | (2%) 229.23K to 225.01K | 55% |
| 04-Jan-19 5:37 PM View: | Societal Cdmo, Inc. (SCTL) | 02-Jan-19 | Payment of Exercise Duplicate | 4,223 | $7.41 | $31,292.40 | (2%) 229.23K to 225.01K | 55% |
| 14-Feb-19 10:00 PM View: | Societal Cdmo, Inc. (SCTL) | 27-Nov-18 | Gift | 45,000 | -- | -- | (20%) 229.23K to 184.23K | |
| 22-Jan-18 5:25 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-18 | Payment of Exercise | 1,575 | $8.89 | $14,001.80 | (< 1%) 230.81K to 229.23K | 62% |
| 22-Jan-18 5:25 PM View: | Societal Cdmo, Inc. (SCTL) | 18-Jan-18 | Option Exercise | 5,000 | -- | -- | 2% 225.81K to 230.81K | |
| 04-Jan-18 8:45 PM View: | Societal Cdmo, Inc. (SCTL) | 02-Jan-18 | Grant | 50,000 | -- | -- | 28% 175.81K to 225.81K | |
| 02-Oct-17 6:41 PM View: | Societal Cdmo, Inc. (SCTL) | 28-Sep-17 | Payment of Exercise | 9,794 | $9.04 | $88,537.80 | (5%) 185.6K to 175.81K | 63% |
| 02-Oct-17 6:41 PM View: | Societal Cdmo, Inc. (SCTL) | 28-Sep-17 | Option Exercise | 31,100 | -- | -- | 20% 154.5K to 185.6K | |
| 09-Jun-15 12:33 PM View: | Societal Cdmo, Inc. (SCTL) | 08-Jun-15 | Market Purchase | 550 | $9.56 | $5,258.00 | < 1% 103.95K to 104.5K | (62%) |
| 09-Jun-15 12:33 PM View: | Societal Cdmo, Inc. (SCTL) | 05-Jun-15 | Market Purchase | 3,950 | $8.83 | $34,878.50 | 4% 100.0K to 103.95K | (59%) |
| 17-Jan-14 5:11 PM View: | Alkermes Plc. (ALKS) | 15-Jan-14 | Option Exercise | 40,000 | $15.40 | $616,200.00 | 100% 0 to 40.0K | |
| 17-Jan-14 5:11 PM View: | Alkermes Plc. (ALKS) | 15-Jan-14 | Market Option Sale (Planned) | 40,000 | $47.57 | $1,902,770.00 | (100%) 40.0K to 0 | 55% |
| 30-Aug-13 5:15 PM View: | Alkermes Plc. (ALKS) | 29-Aug-13 | Option Exercise | 20,000 | $13.44 | $268,800.00 | 100% 0 to 20.0K | |
| 30-Aug-13 5:15 PM View: | Alkermes Plc. (ALKS) | 29-Aug-13 | Market Option Sale (Planned) | 20,000 | $31.68 | $633,532.00 | (100%) 20.0K to 0 | 32% |
| 04-Mar-13 7:40 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 28-Feb-13 | Option Exercise | 10,000 | $12.06 | $120,650.00 | 100% 0 to 10.0K | |
| 04-Mar-13 7:40 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 28-Feb-13 | Planned Private Option Sale | 10,000 | $25.00 | $250,000.00 | (100%) 10.0K to 0 | |
| 27-Nov-12 2:38 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 23-Nov-12 | Option Exercise | 5,240 | $2.49 | $13,027.60 | 100% 0 to 5.24K | 59% |
| 27-Nov-12 2:38 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 23-Nov-12 | Planned Private Option Sale | 5,240 | $15.00 | $78,600.00 | (100%) 5.24K to 0 | |
| 28-Aug-12 5:12 PM View: | Alkermes Plc. (ALKS) | 27-Aug-12 | Option Exercise | 20,000 | $11.44 | $228,800.00 | 100% 0 to 20.0K | |
| 28-Aug-12 5:12 PM View: | Alkermes Plc. (ALKS) | 27-Aug-12 | Market Option Sale (Planned) | 20,000 | $17.80 | $355,990.00 | (100%) 20.0K to 0 | (21%) |
| 28-Aug-12 5:12 PM View: | Alkermes Plc. (ALKS) | 24-Aug-12 | Option Exercise | 20,000 | $11.84 | $236,800.00 | 100% 0 to 20.0K | |
| 28-Aug-12 5:12 PM View: | Alkermes Plc. (ALKS) | 24-Aug-12 | Market Option Sale (Planned) | 20,000 | $17.94 | $358,842.00 | (100%) 20.0K to 0 | (20%) |
| 23-Feb-12 4:10 PM View: | Alkermes Plc. (ALKS) | 23-Feb-12 | Option Exercise | 1,600 | $8.98 | $14,368.00 | 100% 0 to 1.6K |